慢性肺曲霉病中干扰素-γ产生缺陷常见
该研究比较了133例慢性肺曲霉病(CPA)患者与健康对照者的全血细胞因子谱,发现CPA患者对β-葡聚糖+IL-12、LPS+IL-12、酵母聚糖+IL-12及IL-18+IL-12刺激后干扰素-γ(IFNγ)产生显著减少,且高IFNγ产生与死亡率降低相关,作者认为IFNγ免疫治疗可能对IFNγ产生受损的CPA患者有益。
要点
- CPA患者全血对β-葡聚糖+IL-12等刺激的IFNγ产生显著低于健康对照。
- 年龄>60岁和慢阻肺与更差生存相关,高IFNγ产生与死亡率降低相关。
- 作者认为IFNγ免疫治疗可能对IFNγ产生受损的CPA患者有益。
核心结论
- CPA患者外周血对刺激物的IFNγ产生受损,IFNγ产生缺陷与更差结局相关,作者认为IFNγ免疫治疗可能对IFNγ产生受损的CPA患者有益。
研究设计与样本
- 研究比较了CPA患者与健康对照者的外周血细胞因子谱,并分析其与疾病严重程度和死亡率的关系。
- 共评估133例患者(57.1%男性,平均年龄61岁)的细胞因子谱。
主要发现
- 与对照相比,CPA患者对β-葡聚糖+IL-12刺激的IFNγ产生显著减少(312 vs 988 pg/mL)。
- 与对照相比,CPA患者对LPS+IL-12刺激的IFNγ产生显著减少(252 vs 1033 pg/mL)。
- 与对照相比,CPA患者对酵母聚糖+IL-12刺激的IFNγ产生显著减少(996 vs 2347 pg/mL)。
- 与对照相比,CPA患者对IL-18+IL-12刺激的IFNγ产生显著减少(7193 vs 12330 pg/mL)。
- 年龄>60岁(HR 1.71;95%CI 1.00-2.91;P=.05)和慢阻肺(HR 1.69;95%CI 1.03-2.78;P=.039)与更差生存相关,对β-葡聚糖+IL-12刺激的高IFNγ产生(HR 0.48;95%CI 0.25-0.92;P=.026)与死亡率降低相关。
临床怎么用
- 作者认为IFNγ免疫治疗可能对IFNγ产生受损的CPA患者有益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immune defects in chronic pulmonary aspergillosis (CPA) are poorly characterized. We compared peripheral blood cytokine profiles in patients with CPA versus healthy controls and explored the relationship with disease severity. METHODS: Interferon-gamma (IFNγ), interleukin (IL)-17, tumor necrosis factor-α, IL-6, IL-12, and IL-10 were measured after in vitro stimulation of whole blood with lipopolysaccharide (LPS), phytohemagglutinin, β-glucan, zymosan (ZYM), IL-12 or IL-18, and combinations. Clinical parameters and mortality were correlated with cytokine production. RESULTS: Cytokine profiles were evaluated in 133 patients (57.1% male, mean age 61 years). In comparison to controls, patients with CPA had significantly reduced production of IFNγ in response to stimulation with β-glucan + IL-12 (312 vs 988 pg/mL), LPS + IL-12 (252 vs 1033 pg/mL), ZYM + IL-12 (996 vs 2347 pg/mL), and IL-18 + IL-12 (7193 vs 12 330 pg/mL). Age >60 (hazard ratio [HR], 1.71; 95% confidence interval [CI], 1.00-2.91; P = .05) and chronic obstructive pulmonary disease (HR, 1.69; 95% CI, 1.03-2.78; P = .039) were associated with worse survival, whereas high IFNγ production in response to beta-glucan + IL-12 stimulation (HR, 0.48; 95% CI, .25-0.92; P = .026) was associated with reduced mortality. CONCLUSIONS: Patients with CPA show impaired IFNγ production in peripheral blood in response to stimuli. Defective IFNγ production ability correlates with worse outcomes. Immunotherapy with IFNγ could be beneficial for patients showing impaired IFNγ production in CPA.
引用
- Colombo SAP, Hashad R, Denning DW, et al. Defective Interferon-Gamma Production Is Common in Chronic Pulmonary Aspergillosis. J Infect Dis. 2022. PMID: 34850023. doi:10.1093/infdis/jiab583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。